International Journal of Cardiovascular ResearchISSN: 2324-8602

Reach Us +1 850 900 2634

Review Article, Int J Cardiovasc Res Vol: 2 Issue: 5

Cardiac Troponins and Chronic Kidney Disease, What do we Know?

Borja Quiroga*, David Arroyo, Marian Goicoechea, Soledad García de Vinuesa and José Luño
Nephrology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
Corresponding author : Dr. Borja Quiroga
Nephrology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
Tel: +34915868319; Fax: +34915868386
E-mail: [email protected]
Received: August 05, 2013 Accepted: September 23, 2013 Published: September 26, 2013
Citation: Quiroga B, Arroyo D, Goicoechea M, de Vinuesa SG, Luño J (2013) Cardiac Troponins and Chronic Kidney Disease, What do we Know? Int J Cardiovasc Res 2:5. doi:10.4172/2324-8602.1000144

Abstract

Cardiac Troponins and Chronic Kidney Disease, What do we Know?

Cardiovascular disease (CVD) is the first cause of mortality in patients with chronic kidney disease. Identifying patients at high risk for CVD is a diagnostic challenge for nephrologists and other clinicians. In the last decades, new biomarkers of myocardial damage have appeared, such as cardiac troponins. Their prognostic value has been widely studied in patients with impaired renal function. However, it has not yet been possible to make a good prognostic stratification of these patients, since the conclusions of the different studies are diverse.

Keywords: Chronic kidney disease, Glomerular filtration rate, Blood or urinary renal damage markers

Track Your Manuscript

Share This Page

Media Partners